Consultation on cannabis regulatory issues

From Health Canada

The Notice of Intent in the Canada Gazette, Part I provided interested stakeholders with the opportunity to comment on Health Canada’s intent to amend the Cannabis Regulations and associated regulatory frameworks to allow for non-therapeutic cannabis research involving human participants and cannabis testing. This notice also provided interested stakeholders with the opportunity to provide feedback and comment on additional regulatory issues.

Who was the focus of this consultation

Health Canada engaged with Canadians, including:

• provinces, territories and municipalities
• Indigenous peoples
• industry
• academia
• the public health community
• law enforcement

Key issues discussed

The Notice of Intent touched on the following issues under the Cannabis Regulations:

• non-therapeutic cannabis research involving human participants
• cannabis testing
• public possession limits (namely, amounts of various classes of cannabis that are equivalent to 1 gram of dried cannabis, as set out in Schedule 3 to the Cannabis Act)
• product labelling requirements
• micro-class and nursery licensing regime
• measures to support cannabis licence holders with difficulties they might have because of COVID-19

The input gathered through this process will be used to inform regulatory development.

Contact us

Regulatory Affairs
Strategic Policy, Cannabis
Controlled Substances and Cannabis Branch
Health Canada

Email: cannabis.consultation@canada.ca